CN104688944A - External application plaster for treating early stage suppurative osteomyelitis - Google Patents
External application plaster for treating early stage suppurative osteomyelitis Download PDFInfo
- Publication number
- CN104688944A CN104688944A CN201310644800.2A CN201310644800A CN104688944A CN 104688944 A CN104688944 A CN 104688944A CN 201310644800 A CN201310644800 A CN 201310644800A CN 104688944 A CN104688944 A CN 104688944A
- Authority
- CN
- China
- Prior art keywords
- parts
- external application
- plaster
- early stage
- application plaster
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention relates to an external application plaster for treating suppurative osteomyelitis, and belongs to the technical field of traditional Chinese medicinal preparations. The external application plaster is mainly prepared by using honeysuckle flower, Radix Scutellariae, wild chrysanthemum flower, dahurian angelica root, Fructus Gardeniae and other two raw medicines, and the above raw medicines are processed through a pharmacy device to prepare the plaster for external application. The external application plaster has heat clearing, dampness eliminating, toxin draining and pus expelling functions, has a good early stage suppurative osteomyelitis treatment effect, is safe and has no toxic side effects.
Description
Technical field
The invention belongs to technical field of traditional Chinese medicine preparation.
Background technology
Pyogenic infection of the bone, modern medicine is referred to as suppurative osteomyelitis, is apt to occur in child.Generally be divided into early stage, pus to become phase and Collapse later stage three phases, its treatment means is different.Early stage ill time shiver with cold high heat, to the bone, 1-2 are namely stiff for limb pain, and the micro-red slight fever of the then skin that continues, fat swollen bone is swollen.If can effectively treat as early as possible, the state of an illness can be made to obtain early controlling to recover, alleviate patient's slight illness.Modern medicine generally uses antibiotic to the treatment that this demonstrate,proves, but in recent years due to abuse of antibiotics, makes pathogenic bacteria create Drug resistance, adds treatment difficulty and toxic and side effects.
Summary of the invention
The object of the invention is to overcome the deficiencies in the prior art, a kind of external plaster application agent for the treatment of early stage pyogenic infection of the bone is provided.It has clearing away heat and eliminating dampness, the function of expelling pus and toxin by strengthening QI, can spread on lesion directly outward, and it is effective to treat early stage pyogenic infection of the bone.Determined curative effect can be reached, the object of safe without toxic side effect.
The technical solution adopted for the present invention to solve the technical problems is: be made up of Flos Lonicerae, Radix Scutellariae, Flos Chrysanthemi Indici, the Radix Angelicae Dahuricae, Herba Violae, Fructus Gardeniae, Herba Taraxaci 7 kinds of crude drug.
About ingredient major function and preparation in invention formulation.
Flos Lonicerae in the present invention, nature and flavor are sweet, cold.Containing Flos Lonicerae glycoside, inositol, Saponin etc.Heat-clearing and toxic substances removing.Cure mainly epidemic febrile disease heating, carbuncle, scabies, malignant boil, toxic swelling, toxic-heat and blood stasis, pneumonia, laryngopharynx swelling and pain, anemopyretic cold etc.
Radix Scutellariae in the present invention, nature and flavor are bitter, cold.Containing baicalin, wogonoside, glucuronic acid, enzyme etc.Clearing away damp-heat, purte the white, antiabortive removing toxic substances.Cure mainly jaundice due to damp-heat, cough due to lung-heat, ulcer sores, frequent fetal movement.
Flos Chrysanthemi Indici in the present invention, nature and flavor are bitter, pungent, are slightly cold.Heat-clearing and toxic substances removing.Cure mainly carbuncle, furunculosis, laryngopharynx swelling and pain, wind-fire acute conjunctivitis, skin pruritus etc.
The Radix Angelicae Dahuricae in the present invention, nature and flavor are pungent, temperature.Containing Radix Angelicae Dahuricae element, Radix Angelicae Dahuricae ether, phellopterin etc.Expelling pathogenic wind and eliminating dampness, promoting blood circulation and stopping pain, granulation promoting evacuation of pus.Cure mainly flu headache, supraorbital pain, toothache, nasal sinusitis, hemorrhoidal hamorrhage anal fistula, leucorrhea with red and white discharge, carbuncle epidemic disease poison, skin pruritus.
Herba Violae in the present invention, nature and flavor are bitter, cold.Containing glycoside, flavonoid, wax etc.Heat-clearing and toxic substances removing.Cure mainly ulcer sores, scrofula malignant boil.
Fructus Gardeniae in the present invention, nature and flavor are bitter, cold.Containing gardenoside, flavochrome, amaroid, quintessence oil, mannitol, choline etc.Heat clearing away, diuresis, removing heat from blood.Cure mainly calentura dysphoria and insomnia, thirsty, pharyngalgia, conjunctival congestion, jaundice, unable, spit blood, epistaxis, dysentery is had blood in stool.External treatment traumatic injury, dampens, swells and ache.
Herba Taraxaci in the present invention, nature and flavor are bitter, sweet, cold.Containing taraxasterol, taraxacin, glucose, pectin, caffeic acid etc.Heat clearing away, removing toxic substances, eliminating stagnation.Cure mainly taste stagnated fire, acute mastitis, scrofula, pyretic stranguria, lymphadenitis.
The etiology and pathogenesis of pyogenic infection of the bone is that remaining heresy is clear, damp and hot interior Sheng, in poison gos deep into, or extrinsic damage, it is evil that local bone damage experiences again poison, blood stasis heat-transformation, so that meridians block, and sluggish muscles and bones is for suffering from.The present invention has clearing away heat and eliminating dampness, the function of expelling pus and toxin by strengthening QI, can spread on lesion directly outward, and it is effective to treat early stage pyogenic infection of the bone.The invention has the beneficial effects as follows through the early stage pyogenic infection of the bone determined curative effect of clinical practice proof treatment, safe without toxic side effect.
Detailed description of the invention
1. formula and part by weight: Flos Lonicerae 30 parts, Radix Scutellariae 18 parts, Flos Chrysanthemi Indici 35 parts, the Radix Angelicae Dahuricae 16 parts, Herba Violae 40 parts, Fructus Gardeniae 15 parts, Herba Taraxaci 50 parts.
2. manufacture method: weighed in proportion by above-mentioned raw materials medicine and assort, it is qualified to concoct with pharmaceutical equipment apparatus, and purification makes fine powder after concentrating and blender is modulated into paste, is applied in dressing and makes plaster external.
Claims (1)
1. treat an external plaster application agent for early stage pyogenic infection of the bone, it is characterized in that formula and part by weight are Flos Lonicerae 30 parts, Radix Scutellariae 18 parts, Flos Chrysanthemi Indici 35 parts, the Radix Angelicae Dahuricae 16 parts, Herba Violae 40 parts, Fructus Gardeniae 15 parts, Herba Taraxaci 50 parts; Weighed in proportion by above-mentioned raw materials medicine and assort, it is qualified to concoct with pharmaceutical equipment apparatus, and purification makes fine powder after concentrating and blender is modulated into paste in proportion, is applied in dressing and makes plaster external.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310644800.2A CN104688944A (en) | 2013-12-05 | 2013-12-05 | External application plaster for treating early stage suppurative osteomyelitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310644800.2A CN104688944A (en) | 2013-12-05 | 2013-12-05 | External application plaster for treating early stage suppurative osteomyelitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104688944A true CN104688944A (en) | 2015-06-10 |
Family
ID=53336768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310644800.2A Pending CN104688944A (en) | 2013-12-05 | 2013-12-05 | External application plaster for treating early stage suppurative osteomyelitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104688944A (en) |
-
2013
- 2013-12-05 CN CN201310644800.2A patent/CN104688944A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104606385A (en) | Traditional Chinese medicine preparation for treating paronychia | |
| CN104623112A (en) | Plaster for treating snake-head furuncle | |
| CN104688944A (en) | External application plaster for treating early stage suppurative osteomyelitis | |
| CN104688946A (en) | Medicine for treating early suppurative osteomyelitis | |
| CN104606389A (en) | Medicament for treating face furunculosis | |
| CN104587021A (en) | External application preparation for treatment of umbilical carbuncle | |
| CN104606387A (en) | Poison drawing out ointment | |
| CN104606401A (en) | Medicament for treating umbilical abscess | |
| CN104644837A (en) | Externally-applied medicine for treating perforated folliculitis | |
| CN104644892A (en) | Cutaneous anthrax treating drug | |
| CN104623111A (en) | Drug for treating palmar furuncle | |
| CN104688945A (en) | Plaster for the treatment of suppurative osteomyelitis in pus formation period | |
| CN104606329A (en) | Ointment for treating gluteal abscess | |
| CN104623113A (en) | Drug for treating snake belly furuncle | |
| CN104666454A (en) | Plaster for preventing and treating deficiency-type carbuncle | |
| CN105012447A (en) | Medicine for treating qi-blood deficiency vulval swelling | |
| CN104587157A (en) | Ointment for treatment of scrotal abscess | |
| CN104688825A (en) | External plaster for treatment of suppurative osteomyelitis | |
| CN104623115A (en) | Traditional Chinese medicine preparation for treating acute lymphangitis | |
| CN104688943A (en) | Preparation for treating suppurative osteomyelitis in pus formation stage | |
| CN104940348A (en) | Plaster for treating ulcer later suppurative osteomyelitis | |
| CN104623116A (en) | Externally-applied preparation for treating cutaneous anthrax | |
| CN104940579A (en) | Plaster for treating fire invasion type gangrene with internal invasion | |
| CN104510851A (en) | Axilla carbuncle treatment external application preparation | |
| CN105287806A (en) | External application prescription for treating initial-stage mastitis during pregnancy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150610 |